社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Applemh1928
IP属地：未知
+关注
帖子 · 17
帖子 · 17
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Applemh1928
Applemh1928
·
2021-12-08
[Miser] [Miser]
Pfizer, BioNTech say third dose neutralizes Omicron variant<blockquote>辉瑞和BioNTech表示第三剂疫苗可以中和奥密克戎病毒变种</blockquote>
Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on
Pfizer, BioNTech say third dose neutralizes Omicron variant<blockquote>辉瑞和BioNTech表示第三剂疫苗可以中和奥密克戎病毒变种</blockquote>
看
2,231
回复
1
点赞
5
编组 21备份 2
分享
举报
Applemh1928
Applemh1928
·
2021-10-25
[财迷]
非常抱歉，此主贴已删除
看
2,039
回复
评论
点赞
3
编组 21备份 2
分享
举报
Applemh1928
Applemh1928
·
2021-10-04
[财迷] [财迷] [财迷]
非常抱歉，此主贴已删除
看
2,472
回复
评论
点赞
1
编组 21备份 2
分享
举报
Applemh1928
Applemh1928
·
2021-09-16
Love it
非常抱歉，此主贴已删除
看
1,572
回复
评论
点赞
1
编组 21备份 2
分享
举报
Applemh1928
Applemh1928
·
2021-09-15
Going for long term
Globalstar stock rallied 5% in morning trading<blockquote>Globalstar股价早盘上涨5%</blockquote>
Globalstar stock rallied 5% in morning trading. Shares of Globalstar Inc. tumbled 23.3% on Tuesday,
Globalstar stock rallied 5% in morning trading<blockquote>Globalstar股价早盘上涨5%</blockquote>
看
1,715
回复
评论
点赞
8
编组 21备份 2
分享
举报
Applemh1928
Applemh1928
·
2021-09-15
Can consider ipad
非常抱歉，此主贴已删除
看
1,332
回复
评论
点赞
3
编组 21备份 2
分享
举报
Applemh1928
Applemh1928
·
2021-09-13
Holding Long term
非常抱歉，此主贴已删除
看
1,415
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Applemh1928
Applemh1928
·
2021-09-13
[财迷] [财迷] [财迷]
Toplines Before US Market Open on Monday<blockquote>周一美国市场开盘前的顶线</blockquote>
U.S. stock index futures rose on Monday after the S&P 500 logged its worst week in more than two mon
Toplines Before US Market Open on Monday<blockquote>周一美国市场开盘前的顶线</blockquote>
看
2,698
回复
评论
点赞
1
编组 21备份 2
分享
举报
Applemh1928
Applemh1928
·
2021-09-13
Oh
Tech Stocks Roundup: Google is the 'Cheapest of FAANG'<blockquote>科技股综述：谷歌是“FAANG中最便宜的”</blockquote>
Apple (AAPL) investor expectations "remain muted" ahead of the computer giant's iPhone 13 unveiling
Tech Stocks Roundup: Google is the 'Cheapest of FAANG'<blockquote>科技股综述：谷歌是“FAANG中最便宜的”</blockquote>
看
2,974
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Applemh1928
Applemh1928
·
2021-09-12
Like and comment thanks
US IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week<blockquote>美国IPO周：秋季IPO市场以10周IPO拉开帷幕</blockquote>
After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion i
US IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week<blockquote>美国IPO周：秋季IPO市场以10周IPO拉开帷幕</blockquote>
看
1,831
回复
1
点赞
3
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4089370506564720","uuid":"4089370506564720","gmtCreate":1626269120567,"gmtModify":1628043335779,"name":"Applemh1928","pinyin":"applemh1928","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/3b67986ce8802c4167afe02def3d8349","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":11,"tweetSize":17,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.81%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.12","exceedPercentage":"93.26%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":602305176,"gmtCreate":1638967612669,"gmtModify":1638967612800,"author":{"id":"4089370506564720","authorId":"4089370506564720","name":"Applemh1928","avatar":"https://static.tigerbbs.com/3b67986ce8802c4167afe02def3d8349","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089370506564720","idStr":"4089370506564720"},"themes":[],"htmlText":"[Miser] [Miser] ","listText":"[Miser] [Miser] ","text":"[Miser] [Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602305176","repostId":"1177589023","repostType":2,"repost":{"id":"1177589023","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638964838,"share":"https://www.laohu8.com/m/news/1177589023?lang=zh_CN&edition=full","pubTime":"2021-12-08 20:00","market":"us","language":"en","title":"Pfizer, BioNTech say third dose neutralizes Omicron variant<blockquote>辉瑞和BioNTech表示第三剂疫苗可以中和奥密克戎病毒变种</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1177589023","media":"Tiger Newspress","summary":"Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on ","content":"<p>Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on Omicron variant.</p><p><blockquote>辉瑞和biontech股票在提供奥密克戎变种的最新信息后，在盘前交易中收窄了跌幅。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/896ce4e657b0942d9d7a0abce1c3d2f7\" tg-width=\"853\" tg-height=\"622\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/35c4bf42aa2936640aedd52e01beebc5\" tg-width=\"853\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <ul> <li><i>Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers</i></li> <li><i>Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection</i></li> <li><i>As 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease</i></li> <li><i>The companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022</i></li> </ul> Pfizer Inc. and BioNTech SE today announced results from an initial <i>laboratory</i> study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.</p><p><blockquote><ul><li><i>初步实验室研究表明，三剂辉瑞-BioNTech新冠肺炎疫苗中和了奥密克戎变异体（B.1.1.529谱系），而两剂显示中和滴度显著降低</i></li><li><i>数据表明，与针对奥密克戎变体的两个剂量相比，第三个剂量的BNT162b2使中和抗体滴度增加了25倍；加强剂量后的滴度与针对野生型病毒的两次剂量后观察到的滴度相当，其与高水平的保护相关</i></li><li><i>由于CD8+T细胞识别的刺突蛋白中80%的表位不受奥密克戎变异体突变的影响，两次剂量仍可能诱导对严重疾病的保护</i></li><li><i>两家公司继续推进针对奥密克戎病毒的变异特异性疫苗的开发，预计如果需要进行调整以进一步提高保护水平和持续时间，将在3月份之前上市-预计两家公司的疫苗不会发生变化2022年40亿剂产能</i></li></ul>辉瑞公司和BioNTech SE今天公布了初步结果<i>实验室</i>研究表明，辉瑞-BioNTech新冠肺炎疫苗（BNT162b2）诱导的血清抗体在三剂后中和新型冠状病毒奥密克戎变异体。在接受加强疫苗接种（第三剂BNT162b2疫苗）后一个月从接种者获得的血清中和了奥密克戎变异体，其水平与两剂后观察到的野生型新型冠状病毒刺突蛋白相当。</blockquote></p><p> Sera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.</p><p><blockquote>与野生型相比，接受两剂当前新冠肺炎疫苗的个体的血清对奥密克戎变异体的中和滴度平均降低了25倍以上，这表明两剂BNT162b2可能不足以预防奥密克戎变异体的感染。然而，由于疫苗诱导的T细胞靶向的绝大多数表位不受奥密克戎病突变的影响，两家公司认为，接种疫苗的个体可能仍然可以预防严重形式的疾病，并正在密切监测全球范围内针对奥密克戎的真实有效性。</blockquote></p><p> A more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.</p><p><blockquote>第三剂可以实现更强大的保护，因为两家公司的其他研究数据表明，辉瑞和BioNTech的当前新冠肺炎疫苗的加强剂可以将抗体滴度提高25倍。根据两家公司的初步数据，第三剂疫苗提供的奥密克戎中和抗体水平与针对野生型和奥密克戎之前出现的其他变种的两剂疫苗后观察到的相似。这些抗体水平与针对野生型病毒和这些变体两者的高功效相关。第三剂量还强烈增加针对多个刺突蛋白表位的CD8+T细胞水平，所述多个刺突蛋白表位被认为与针对严重疾病的保护相关。与野生型病毒相比，这些表位中的绝大多数在奥密克戎刺突变体中保持不变。</blockquote></p><p> “Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said <b>Albert Bourla, Chairman and Chief Executive Officer, Pfizer</b>. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”</p><p><blockquote>“虽然两剂疫苗可能仍然可以预防由奥密克戎毒株引起的严重疾病，但从这些初步数据可以清楚地看出，第三剂我们的疫苗可以提高保护作用，”他说。<b>Albert Bourla，辉瑞公司董事长兼首席执行官</b>.“确保尽可能多的人完全接种前两剂系列疫苗和加强剂仍然是防止COVID-19传播的最佳行动方案。”</blockquote></p><p> “Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said <b>Ugur Sahin, M.D., CEO and Co-Founder of BioNTech</b>. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”</p><p><blockquote>“我们的初步、第一个数据集表明，第三剂疫苗仍然可以提供足够的保护，预防由奥密克戎变种引起的任何严重程度的疾病，”他说。<b>Ugur Sahin，医学博士，BioNTech首席执行官兼联合创始人</b>“世界各地广泛的疫苗接种和加强疫苗接种活动可以帮助我们更好地保护世界各地的人们并度过冬季。我们继续研究一种适应性疫苗，我们相信这将有助于诱导针对奥密克戎引起的COVID-19疾病的高水平保护，与目前的疫苗相比，保护时间更长。”</blockquote></p><p></p><p> While these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta & Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.</p><p><blockquote>虽然这些结果是初步的，但两家公司将继续收集更多的实验室数据并评估现实世界的有效性，以评估和确认对奥密克戎的保护，并为最有效的前进道路提供信息。11月25日，两家公司开始开发一种针对奥密克戎的COVID-19疫苗。如果需要调整疫苗以提高对奥密克戎的保护水平和持续时间，开发将按计划继续进行。第一批基于奥密克戎的疫苗可以生产，并计划在100天内准备好交付，等待监管部门的批准。辉瑞和BioNTech也测试了其他变异特异性疫苗，这些疫苗产生了非常强的中和滴度和可耐受的安全性。基于这一经验，这些公司非常有信心，如果需要，他们可以在2022年3月交付基于奥密克戎的疫苗。这些公司此前还启动了变异特异性疫苗（Alpha、Beta、Delta和Alpha/Delta Mix）的临床试验，这些研究的数据将提交给世界各地的监管机构，以帮助加快适应疫苗的过程，并在需要时获得奥密克戎特异性疫苗的监管授权或批准。两家公司此前曾宣布，他们预计在2022年生产40亿剂BNT162b2，如果需要适应的疫苗，预计这一产能不会改变。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer, BioNTech say third dose neutralizes Omicron variant<blockquote>辉瑞和BioNTech表示第三剂疫苗可以中和奥密克戎病毒变种</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, BioNTech say third dose neutralizes Omicron variant<blockquote>辉瑞和BioNTech表示第三剂疫苗可以中和奥密克戎病毒变种</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-08 20:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on Omicron variant.</p><p><blockquote>辉瑞和biontech股票在提供奥密克戎变种的最新信息后，在盘前交易中收窄了跌幅。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/896ce4e657b0942d9d7a0abce1c3d2f7\" tg-width=\"853\" tg-height=\"622\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/35c4bf42aa2936640aedd52e01beebc5\" tg-width=\"853\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <ul> <li><i>Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers</i></li> <li><i>Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection</i></li> <li><i>As 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease</i></li> <li><i>The companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022</i></li> </ul> Pfizer Inc. and BioNTech SE today announced results from an initial <i>laboratory</i> study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.</p><p><blockquote><ul><li><i>初步实验室研究表明，三剂辉瑞-BioNTech新冠肺炎疫苗中和了奥密克戎变异体（B.1.1.529谱系），而两剂显示中和滴度显著降低</i></li><li><i>数据表明，与针对奥密克戎变体的两个剂量相比，第三个剂量的BNT162b2使中和抗体滴度增加了25倍；加强剂量后的滴度与针对野生型病毒的两次剂量后观察到的滴度相当，其与高水平的保护相关</i></li><li><i>由于CD8+T细胞识别的刺突蛋白中80%的表位不受奥密克戎变异体突变的影响，两次剂量仍可能诱导对严重疾病的保护</i></li><li><i>两家公司继续推进针对奥密克戎病毒的变异特异性疫苗的开发，预计如果需要进行调整以进一步提高保护水平和持续时间，将在3月份之前上市-预计两家公司的疫苗不会发生变化2022年40亿剂产能</i></li></ul>辉瑞公司和BioNTech SE今天公布了初步结果<i>实验室</i>研究表明，辉瑞-BioNTech新冠肺炎疫苗（BNT162b2）诱导的血清抗体在三剂后中和新型冠状病毒奥密克戎变异体。在接受加强疫苗接种（第三剂BNT162b2疫苗）后一个月从接种者获得的血清中和了奥密克戎变异体，其水平与两剂后观察到的野生型新型冠状病毒刺突蛋白相当。</blockquote></p><p> Sera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.</p><p><blockquote>与野生型相比，接受两剂当前新冠肺炎疫苗的个体的血清对奥密克戎变异体的中和滴度平均降低了25倍以上，这表明两剂BNT162b2可能不足以预防奥密克戎变异体的感染。然而，由于疫苗诱导的T细胞靶向的绝大多数表位不受奥密克戎病突变的影响，两家公司认为，接种疫苗的个体可能仍然可以预防严重形式的疾病，并正在密切监测全球范围内针对奥密克戎的真实有效性。</blockquote></p><p> A more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.</p><p><blockquote>第三剂可以实现更强大的保护，因为两家公司的其他研究数据表明，辉瑞和BioNTech的当前新冠肺炎疫苗的加强剂可以将抗体滴度提高25倍。根据两家公司的初步数据，第三剂疫苗提供的奥密克戎中和抗体水平与针对野生型和奥密克戎之前出现的其他变种的两剂疫苗后观察到的相似。这些抗体水平与针对野生型病毒和这些变体两者的高功效相关。第三剂量还强烈增加针对多个刺突蛋白表位的CD8+T细胞水平，所述多个刺突蛋白表位被认为与针对严重疾病的保护相关。与野生型病毒相比，这些表位中的绝大多数在奥密克戎刺突变体中保持不变。</blockquote></p><p> “Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said <b>Albert Bourla, Chairman and Chief Executive Officer, Pfizer</b>. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”</p><p><blockquote>“虽然两剂疫苗可能仍然可以预防由奥密克戎毒株引起的严重疾病，但从这些初步数据可以清楚地看出，第三剂我们的疫苗可以提高保护作用，”他说。<b>Albert Bourla，辉瑞公司董事长兼首席执行官</b>.“确保尽可能多的人完全接种前两剂系列疫苗和加强剂仍然是防止COVID-19传播的最佳行动方案。”</blockquote></p><p> “Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said <b>Ugur Sahin, M.D., CEO and Co-Founder of BioNTech</b>. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”</p><p><blockquote>“我们的初步、第一个数据集表明，第三剂疫苗仍然可以提供足够的保护，预防由奥密克戎变种引起的任何严重程度的疾病，”他说。<b>Ugur Sahin，医学博士，BioNTech首席执行官兼联合创始人</b>“世界各地广泛的疫苗接种和加强疫苗接种活动可以帮助我们更好地保护世界各地的人们并度过冬季。我们继续研究一种适应性疫苗，我们相信这将有助于诱导针对奥密克戎引起的COVID-19疾病的高水平保护，与目前的疫苗相比，保护时间更长。”</blockquote></p><p></p><p> While these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta & Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.</p><p><blockquote>虽然这些结果是初步的，但两家公司将继续收集更多的实验室数据并评估现实世界的有效性，以评估和确认对奥密克戎的保护，并为最有效的前进道路提供信息。11月25日，两家公司开始开发一种针对奥密克戎的COVID-19疫苗。如果需要调整疫苗以提高对奥密克戎的保护水平和持续时间，开发将按计划继续进行。第一批基于奥密克戎的疫苗可以生产，并计划在100天内准备好交付，等待监管部门的批准。辉瑞和BioNTech也测试了其他变异特异性疫苗，这些疫苗产生了非常强的中和滴度和可耐受的安全性。基于这一经验，这些公司非常有信心，如果需要，他们可以在2022年3月交付基于奥密克戎的疫苗。这些公司此前还启动了变异特异性疫苗（Alpha、Beta、Delta和Alpha/Delta Mix）的临床试验，这些研究的数据将提交给世界各地的监管机构，以帮助加快适应疫苗的过程，并在需要时获得奥密克戎特异性疫苗的监管授权或批准。两家公司此前曾宣布，他们预计在2022年生产40亿剂BNT162b2，如果需要适应的疫苗，预计这一产能不会改变。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177589023","content_text":"Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on Omicron variant.\n\n\nPreliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers\nData indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection\nAs 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease\nThe companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022\n\nPfizer Inc. and BioNTech SE today announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.\nSera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.\nA more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.\n“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”\n“Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said Ugur Sahin, M.D., CEO and Co-Founder of BioNTech. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”\nWhile these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta & Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":2231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856633838,"gmtCreate":1635172353046,"gmtModify":1635172353624,"author":{"id":"4089370506564720","authorId":"4089370506564720","name":"Applemh1928","avatar":"https://static.tigerbbs.com/3b67986ce8802c4167afe02def3d8349","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089370506564720","idStr":"4089370506564720"},"themes":[],"htmlText":"[财迷] ","listText":"[财迷] ","text":"[财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856633838","repostId":"2178950426","repostType":4,"isVote":1,"tweetType":1,"viewCount":2039,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820344033,"gmtCreate":1633355883839,"gmtModify":1633355985746,"author":{"id":"4089370506564720","authorId":"4089370506564720","name":"Applemh1928","avatar":"https://static.tigerbbs.com/3b67986ce8802c4167afe02def3d8349","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089370506564720","idStr":"4089370506564720"},"themes":[],"htmlText":"[财迷] [财迷] [财迷] ","listText":"[财迷] [财迷] [财迷] ","text":"[财迷] [财迷] [财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820344033","repostId":"1139003361","repostType":4,"isVote":1,"tweetType":1,"viewCount":2472,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":885181543,"gmtCreate":1631765008082,"gmtModify":1631890655198,"author":{"id":"4089370506564720","authorId":"4089370506564720","name":"Applemh1928","avatar":"https://static.tigerbbs.com/3b67986ce8802c4167afe02def3d8349","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089370506564720","idStr":"4089370506564720"},"themes":[],"htmlText":"Love it","listText":"Love it","text":"Love it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/885181543","repostId":"1195969151","repostType":2,"isVote":1,"tweetType":1,"viewCount":1572,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882789337,"gmtCreate":1631720758529,"gmtModify":1631890655203,"author":{"id":"4089370506564720","authorId":"4089370506564720","name":"Applemh1928","avatar":"https://static.tigerbbs.com/3b67986ce8802c4167afe02def3d8349","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089370506564720","idStr":"4089370506564720"},"themes":[],"htmlText":"Going for long term","listText":"Going for long term","text":"Going for long term","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/882789337","repostId":"1157480105","repostType":4,"repost":{"id":"1157480105","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631714047,"share":"https://www.laohu8.com/m/news/1157480105?lang=zh_CN&edition=full","pubTime":"2021-09-15 21:54","market":"us","language":"en","title":"Globalstar stock rallied 5% in morning trading<blockquote>Globalstar股价早盘上涨5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1157480105","media":"Tiger Newspress","summary":"Globalstar stock rallied 5% in morning trading.\n\nShares of Globalstar Inc. tumbled 23.3% on Tuesday,","content":"<p>Globalstar stock rallied 5% in morning trading.</p><p><blockquote>Globalstar股价早盘上涨5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/28a41b9c5e5150f94d9cca062670298f\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Shares of Globalstar Inc. tumbled 23.3% on Tuesday, as investors expressed disappointment that Apple Inc. did not say its new iPhone 13s would support satellite communications.</p><p><blockquote>全球星公司股价周二暴跌23.3%，投资者对苹果公司没有表示其新款iPhone 13将支持卫星通信表示失望。</blockquote></p><p> The stock had rocketed 64.3% on Aug. 30, after the reports surfaced that Apple would work with Globalstar as it added satellite communications to its next iPhone. The stock had climbed another 14.5% from Aug. 30 to the five-year closing high of $2.69 on Sept. 8, before pulling back. The stock has still rocketed 416.8% year to date, while the S&P 500 has advanced 18.3%.</p><p><blockquote>8月30日，有报道称苹果将与Globalstar合作，在其下一代iPhone中添加卫星通信功能后，该股飙升64.3%。该股较8月30日又上涨14.5%，至9月8日2.69美元的五年收盘高点，随后回落。今年迄今为止，该股仍飙升416.8%，而标普500则上涨了18.3%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Globalstar stock rallied 5% in morning trading<blockquote>Globalstar股价早盘上涨5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGlobalstar stock rallied 5% in morning trading<blockquote>Globalstar股价早盘上涨5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-09-15 21:54</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Globalstar stock rallied 5% in morning trading.</p><p><blockquote>Globalstar股价早盘上涨5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/28a41b9c5e5150f94d9cca062670298f\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Shares of Globalstar Inc. tumbled 23.3% on Tuesday, as investors expressed disappointment that Apple Inc. did not say its new iPhone 13s would support satellite communications.</p><p><blockquote>全球星公司股价周二暴跌23.3%，投资者对苹果公司没有表示其新款iPhone 13将支持卫星通信表示失望。</blockquote></p><p> The stock had rocketed 64.3% on Aug. 30, after the reports surfaced that Apple would work with Globalstar as it added satellite communications to its next iPhone. The stock had climbed another 14.5% from Aug. 30 to the five-year closing high of $2.69 on Sept. 8, before pulling back. The stock has still rocketed 416.8% year to date, while the S&P 500 has advanced 18.3%.</p><p><blockquote>8月30日，有报道称苹果将与Globalstar合作，在其下一代iPhone中添加卫星通信功能后，该股飙升64.3%。该股较8月30日又上涨14.5%，至9月8日2.69美元的五年收盘高点，随后回落。今年迄今为止，该股仍飙升416.8%，而标普500则上涨了18.3%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GSAT":"全球星"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157480105","content_text":"Globalstar stock rallied 5% in morning trading.\n\nShares of Globalstar Inc. tumbled 23.3% on Tuesday, as investors expressed disappointment that Apple Inc. did not say its new iPhone 13s would support satellite communications.\nThe stock had rocketed 64.3% on Aug. 30, after the reports surfaced that Apple would work with Globalstar as it added satellite communications to its next iPhone. The stock had climbed another 14.5% from Aug. 30 to the five-year closing high of $2.69 on Sept. 8, before pulling back. The stock has still rocketed 416.8% year to date, while the S&P 500 has advanced 18.3%.","news_type":1,"symbols_score_info":{"GSAT":0.9}},"isVote":1,"tweetType":1,"viewCount":1715,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882912965,"gmtCreate":1631641584957,"gmtModify":1631890655203,"author":{"id":"4089370506564720","authorId":"4089370506564720","name":"Applemh1928","avatar":"https://static.tigerbbs.com/3b67986ce8802c4167afe02def3d8349","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089370506564720","idStr":"4089370506564720"},"themes":[],"htmlText":"Can consider ipad","listText":"Can consider ipad","text":"Can consider ipad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/882912965","repostId":"1147706594","repostType":4,"isVote":1,"tweetType":1,"viewCount":1332,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":886090318,"gmtCreate":1631535732334,"gmtModify":1631890655207,"author":{"id":"4089370506564720","authorId":"4089370506564720","name":"Applemh1928","avatar":"https://static.tigerbbs.com/3b67986ce8802c4167afe02def3d8349","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089370506564720","idStr":"4089370506564720"},"themes":[],"htmlText":"Holding Long term","listText":"Holding Long term","text":"Holding Long term","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/886090318","repostId":"2166392866","repostType":2,"isVote":1,"tweetType":1,"viewCount":1415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":886005693,"gmtCreate":1631535569712,"gmtModify":1631890655211,"author":{"id":"4089370506564720","authorId":"4089370506564720","name":"Applemh1928","avatar":"https://static.tigerbbs.com/3b67986ce8802c4167afe02def3d8349","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089370506564720","idStr":"4089370506564720"},"themes":[],"htmlText":"[财迷] [财迷] [财迷] ","listText":"[财迷] [财迷] [财迷] ","text":"[财迷] [财迷] [财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/886005693","repostId":"1129341543","repostType":4,"repost":{"id":"1129341543","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631534652,"share":"https://www.laohu8.com/m/news/1129341543?lang=zh_CN&edition=full","pubTime":"2021-09-13 20:04","market":"us","language":"en","title":"Toplines Before US Market Open on Monday<blockquote>周一美国市场开盘前的顶线</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1129341543","media":"Tiger Newspress","summary":"U.S. stock index futures rose on Monday after the S&P 500 logged its worst week in more than two mon","content":"<p>U.S. stock index futures rose on Monday after the S&P 500 logged its worst week in more than two months, with investors keeping a close eye on inflation as well as monetary and tax policies.</p><p><blockquote>美国股指期货周一上涨，此前标普500录得两个多月来最糟糕的一周，投资者密切关注通胀以及货币和税收政策。</blockquote></p><p> S&P 500 E-minis were up 23.25 points, or 0.52% at 08:00 am ET. Dow E-minis were up 183 points, or 0.53%, while Nasdaq 100 E-minis were up 75 points, or 0.49%.</p><p><blockquote>截至美国东部时间上午08:00，标普500 e-mini上涨23.25点，即0.52%。道琼斯电子迷你指数上涨183点，涨幅0.53%，纳斯达克100电子迷你指数上涨75点，涨幅0.49%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/2d51dd22d532e1b98f0ecae05c1f7a3e\" tg-width=\"1080\" tg-height=\"416\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Apple Inc rose 0.9% in premarket trading after a mixed court ruling in Epic Games’ antitrust case against the iPhone maker knocked nearly $90 billion off its market value on Friday.</p><p><blockquote>周五，法院对Epic Games针对iPhone制造商的反垄断案做出了好坏参半的裁决，导致苹果公司市值缩水近900亿美元，该公司在盘前交易中上涨0.9%。</blockquote></p><p> <b>Stocks making the biggest moves in the premarket:</b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b>Virgin Galactic(SPCE)</b> – Virgin Galactic is delaying its first commercial research space mission after a third-party supplier warned of a potential defect in a component of the flight control system. Virgin Galactic shares slid 3.3% in the premarket.</p><p><blockquote><b>维珍银河(SPCE)</b>-在第三方供应商警告飞行控制系统的一个组件存在潜在缺陷后，维珍银河推迟了其首次商业研究太空任务。维珍银河股价盘前下跌3.3%。</blockquote></p><p> <b>Dell Technologies(DELL) </b>– Dell added 1.9% in premarket action after Goldman Sachs added the computer maker’s stock to its “Conviction Buy” list. Goldman cited strong cash flow generation and debt paydown plans, among other factors.</p><p><blockquote><b>戴尔科技(DELL)</b>-高盛将戴尔的股票添加到其“坚定买入”名单后，戴尔在盘前股价上涨1.9%。高盛列举了强劲的现金流生成和债务偿还计划等因素。</blockquote></p><p> <b>TransUnion(TRU)</b> – TransUnion announced a deal to buy closely held information services company Neustar for $3.1 billion in cash. The credit reporting agency expects the deal to close during the fourth quarter.</p><p><blockquote><b>TransUnion(TRU)</b>–TransUnion宣布以31亿美元现金收购少数人持股的信息服务公司Neustar的交易。该信用报告机构预计该交易将在第四季度完成。</blockquote></p><p> <b>Viacom(VIAC) </b>– Viacom is planning a revamp of its Paramount Pictures unit, according to people familiar with the matter who spoke to The Wall Street Journal. The revamp, which would separate the TV and film operations, could be announced as soon as today. Viacom rose 1% in the premarket.</p><p><blockquote><b>维亚康姆(VIAC)</b>-据接受《华尔街日报》采访的知情人士透露，维亚康姆正计划对其派拉蒙影业部门进行重组。这项改革将把电视和电影业务分开，最早可能在今天宣布。维亚康姆盘前上涨1%。</blockquote></p><p> <b>Kansas City Southern(KSU)</b> – Kansas City Southern said the latest takeover bid from Canadian Pacific Railway(CP) is superior to the one it previously agreed to with Canadian National Railway(CNI). Canadian National now has five days to improve its offer, should it choose to do so. Canadian Pacific rallied 0.9% in premarket trading.</p><p><blockquote><b>堪萨斯城南部(KSU)</b>-堪萨斯城南方公司表示，加拿大太平洋铁路公司（CP）的最新收购要约优于此前与加拿大国家铁路公司（CNI）达成的收购要约。如果加拿大国民银行选择这样做，它现在有五天的时间来提高其报价。加拿大太平洋航空在盘前交易中上涨0.9%。</blockquote></p><p> <b>Walt Disney(DIS)</b> – Disney will show the remainder of its 2021 movie releases exclusively in theaters, rather than making them simultaneously available on its Disney+ streaming service. Disney’s “Shang-Chi and the Legend of the 10 Rings” topped the weekend box office once again following its record Labor Day weekend performance, with that movie showing exclusively in theaters.</p><p><blockquote><b>华特迪士尼(DIS)</b>-迪士尼将在影院独家放映2021年上映的剩余电影，而不是在其Disney+流媒体服务上同时播放。迪士尼的《尚气与十环传奇》继劳动节周末创纪录的表现后，再次荣登周末票房榜首，这部电影仅在影院上映。</blockquote></p><p> <b>Alibaba(BABA)</b> – Alibaba fell 1.7% in premarket action.</p><p><blockquote><b>阿里巴巴-SW（父亲）</b>-阿里巴巴-SW盘前下跌1.7%。</blockquote></p><p> <b>Apple(AAPL)</b> – Epic Games will appeal Friday’s ruling that Apple’s app store was not an illegal monopoly. Epic did win a partial victory in the case, with the judge ruling that Apple must allow developers to include external payment links.</p><p><blockquote><b>苹果(AAPL)</b>-Epic Games将对周五的裁决提出上诉，该裁决认为苹果的app store不是非法垄断。Epic在此案中确实取得了部分胜利，法官裁定苹果必须允许开发者包含外部支付链接。</blockquote></p><p> <b>Carlyle Group(CG)</b> – Carlyle is considering a $6 billion sale or initial public offering for packaging company Novolex, according to a Bloomberg report. The private-equity firm bought Novolex for an undisclosed amount in November 2016.</p><p><blockquote><b>凯雷集团(CG)</b>-据彭博社报道，凯雷正在考虑以60亿美元的价格出售或首次公开募股包装公司Novolex。这家私募股权公司于2016年11月收购了Novolex，收购金额未公开。</blockquote></p><p> <b>MGM Resorts(MGM)</b> – MGM rose 1.5% in the premarket after Bernstein upgraded the resort operator’s stock to “outperform” from “market perform,” citing its strong presence in the gaming and sports betting industry as well as moves to divest the company’s real estate portfolio.</p><p><blockquote><b>美高梅度假村(MGM)</b>-米高梅在盘前上涨1.5%，此前伯恩斯坦将这家度假村运营商的股票从“大盘表现”上调至“跑赢大盘”，理由是该公司在博彩和体育博彩行业的强大影响力以及剥离该公司房地产投资组合的举措。</blockquote></p><p> <b>Pfizer(PFE) </b>– Pfizer’s Covid-19 vaccine – developed in conjunction with German partner BioNTech(BNTX) – could be authorized for use in children aged 5-11 as soon as next month, according to two sources familiar with the situation who spoke to Reuters. Pfizer is expected to have enough study data by then to submit an application for emergency use authorization to the Food and Drug Administration. BioNTech added 1.1% in premarket trading.</p><p><blockquote><b>辉瑞(PFE)</b>-据两位知情人士向路透社透露，辉瑞与德国合作伙伴BioNTech(BNTX)联合开发的Covid-19疫苗最早可能于下个月被授权用于5-11岁的儿童。辉瑞预计届时将有足够的研究数据向食品药品监督管理局提交紧急使用授权申请。BioNTech在盘前交易中上涨1.1%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday<blockquote>周一美国市场开盘前的顶线</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday<blockquote>周一美国市场开盘前的顶线</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-09-13 20:04</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S. stock index futures rose on Monday after the S&P 500 logged its worst week in more than two months, with investors keeping a close eye on inflation as well as monetary and tax policies.</p><p><blockquote>美国股指期货周一上涨，此前标普500录得两个多月来最糟糕的一周，投资者密切关注通胀以及货币和税收政策。</blockquote></p><p> S&P 500 E-minis were up 23.25 points, or 0.52% at 08:00 am ET. Dow E-minis were up 183 points, or 0.53%, while Nasdaq 100 E-minis were up 75 points, or 0.49%.</p><p><blockquote>截至美国东部时间上午08:00，标普500 e-mini上涨23.25点，即0.52%。道琼斯电子迷你指数上涨183点，涨幅0.53%，纳斯达克100电子迷你指数上涨75点，涨幅0.49%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/2d51dd22d532e1b98f0ecae05c1f7a3e\" tg-width=\"1080\" tg-height=\"416\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Apple Inc rose 0.9% in premarket trading after a mixed court ruling in Epic Games’ antitrust case against the iPhone maker knocked nearly $90 billion off its market value on Friday.</p><p><blockquote>周五，法院对Epic Games针对iPhone制造商的反垄断案做出了好坏参半的裁决，导致苹果公司市值缩水近900亿美元，该公司在盘前交易中上涨0.9%。</blockquote></p><p> <b>Stocks making the biggest moves in the premarket:</b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b>Virgin Galactic(SPCE)</b> – Virgin Galactic is delaying its first commercial research space mission after a third-party supplier warned of a potential defect in a component of the flight control system. Virgin Galactic shares slid 3.3% in the premarket.</p><p><blockquote><b>维珍银河(SPCE)</b>-在第三方供应商警告飞行控制系统的一个组件存在潜在缺陷后，维珍银河推迟了其首次商业研究太空任务。维珍银河股价盘前下跌3.3%。</blockquote></p><p> <b>Dell Technologies(DELL) </b>– Dell added 1.9% in premarket action after Goldman Sachs added the computer maker’s stock to its “Conviction Buy” list. Goldman cited strong cash flow generation and debt paydown plans, among other factors.</p><p><blockquote><b>戴尔科技(DELL)</b>-高盛将戴尔的股票添加到其“坚定买入”名单后，戴尔在盘前股价上涨1.9%。高盛列举了强劲的现金流生成和债务偿还计划等因素。</blockquote></p><p> <b>TransUnion(TRU)</b> – TransUnion announced a deal to buy closely held information services company Neustar for $3.1 billion in cash. The credit reporting agency expects the deal to close during the fourth quarter.</p><p><blockquote><b>TransUnion(TRU)</b>–TransUnion宣布以31亿美元现金收购少数人持股的信息服务公司Neustar的交易。该信用报告机构预计该交易将在第四季度完成。</blockquote></p><p> <b>Viacom(VIAC) </b>– Viacom is planning a revamp of its Paramount Pictures unit, according to people familiar with the matter who spoke to The Wall Street Journal. The revamp, which would separate the TV and film operations, could be announced as soon as today. Viacom rose 1% in the premarket.</p><p><blockquote><b>维亚康姆(VIAC)</b>-据接受《华尔街日报》采访的知情人士透露，维亚康姆正计划对其派拉蒙影业部门进行重组。这项改革将把电视和电影业务分开，最早可能在今天宣布。维亚康姆盘前上涨1%。</blockquote></p><p> <b>Kansas City Southern(KSU)</b> – Kansas City Southern said the latest takeover bid from Canadian Pacific Railway(CP) is superior to the one it previously agreed to with Canadian National Railway(CNI). Canadian National now has five days to improve its offer, should it choose to do so. Canadian Pacific rallied 0.9% in premarket trading.</p><p><blockquote><b>堪萨斯城南部(KSU)</b>-堪萨斯城南方公司表示，加拿大太平洋铁路公司（CP）的最新收购要约优于此前与加拿大国家铁路公司（CNI）达成的收购要约。如果加拿大国民银行选择这样做，它现在有五天的时间来提高其报价。加拿大太平洋航空在盘前交易中上涨0.9%。</blockquote></p><p> <b>Walt Disney(DIS)</b> – Disney will show the remainder of its 2021 movie releases exclusively in theaters, rather than making them simultaneously available on its Disney+ streaming service. Disney’s “Shang-Chi and the Legend of the 10 Rings” topped the weekend box office once again following its record Labor Day weekend performance, with that movie showing exclusively in theaters.</p><p><blockquote><b>华特迪士尼(DIS)</b>-迪士尼将在影院独家放映2021年上映的剩余电影，而不是在其Disney+流媒体服务上同时播放。迪士尼的《尚气与十环传奇》继劳动节周末创纪录的表现后，再次荣登周末票房榜首，这部电影仅在影院上映。</blockquote></p><p> <b>Alibaba(BABA)</b> – Alibaba fell 1.7% in premarket action.</p><p><blockquote><b>阿里巴巴-SW（父亲）</b>-阿里巴巴-SW盘前下跌1.7%。</blockquote></p><p> <b>Apple(AAPL)</b> – Epic Games will appeal Friday’s ruling that Apple’s app store was not an illegal monopoly. Epic did win a partial victory in the case, with the judge ruling that Apple must allow developers to include external payment links.</p><p><blockquote><b>苹果(AAPL)</b>-Epic Games将对周五的裁决提出上诉，该裁决认为苹果的app store不是非法垄断。Epic在此案中确实取得了部分胜利，法官裁定苹果必须允许开发者包含外部支付链接。</blockquote></p><p> <b>Carlyle Group(CG)</b> – Carlyle is considering a $6 billion sale or initial public offering for packaging company Novolex, according to a Bloomberg report. The private-equity firm bought Novolex for an undisclosed amount in November 2016.</p><p><blockquote><b>凯雷集团(CG)</b>-据彭博社报道，凯雷正在考虑以60亿美元的价格出售或首次公开募股包装公司Novolex。这家私募股权公司于2016年11月收购了Novolex，收购金额未公开。</blockquote></p><p> <b>MGM Resorts(MGM)</b> – MGM rose 1.5% in the premarket after Bernstein upgraded the resort operator’s stock to “outperform” from “market perform,” citing its strong presence in the gaming and sports betting industry as well as moves to divest the company’s real estate portfolio.</p><p><blockquote><b>美高梅度假村(MGM)</b>-米高梅在盘前上涨1.5%，此前伯恩斯坦将这家度假村运营商的股票从“大盘表现”上调至“跑赢大盘”，理由是该公司在博彩和体育博彩行业的强大影响力以及剥离该公司房地产投资组合的举措。</blockquote></p><p> <b>Pfizer(PFE) </b>– Pfizer’s Covid-19 vaccine – developed in conjunction with German partner BioNTech(BNTX) – could be authorized for use in children aged 5-11 as soon as next month, according to two sources familiar with the situation who spoke to Reuters. Pfizer is expected to have enough study data by then to submit an application for emergency use authorization to the Food and Drug Administration. BioNTech added 1.1% in premarket trading.</p><p><blockquote><b>辉瑞(PFE)</b>-据两位知情人士向路透社透露，辉瑞与德国合作伙伴BioNTech(BNTX)联合开发的Covid-19疫苗最早可能于下个月被授权用于5-11岁的儿童。辉瑞预计届时将有足够的研究数据向食品药品监督管理局提交紧急使用授权申请。BioNTech在盘前交易中上涨1.1%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KSU":"堪萨斯南方铁路","MGM":"美高梅","SPCE":"维珍银河","CG":"凯雷","BABA":"阿里巴巴","DELL":"戴尔",".SPX":"S&P 500 Index","AAPL":"苹果","BNTX":"BioNTech SE","TRU":"TransUnion","PFE":"辉瑞","DIS":"迪士尼",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129341543","content_text":"U.S. stock index futures rose on Monday after the S&P 500 logged its worst week in more than two months, with investors keeping a close eye on inflation as well as monetary and tax policies.\nS&P 500 E-minis were up 23.25 points, or 0.52% at 08:00 am ET. Dow E-minis were up 183 points, or 0.53%, while Nasdaq 100 E-minis were up 75 points, or 0.49%.\n\nApple Inc rose 0.9% in premarket trading after a mixed court ruling in Epic Games’ antitrust case against the iPhone maker knocked nearly $90 billion off its market value on Friday.\nStocks making the biggest moves in the premarket:\nVirgin Galactic(SPCE) – Virgin Galactic is delaying its first commercial research space mission after a third-party supplier warned of a potential defect in a component of the flight control system. Virgin Galactic shares slid 3.3% in the premarket.\nDell Technologies(DELL) – Dell added 1.9% in premarket action after Goldman Sachs added the computer maker’s stock to its “Conviction Buy” list. Goldman cited strong cash flow generation and debt paydown plans, among other factors.\nTransUnion(TRU) – TransUnion announced a deal to buy closely held information services company Neustar for $3.1 billion in cash. The credit reporting agency expects the deal to close during the fourth quarter.\nViacom(VIAC) – Viacom is planning a revamp of its Paramount Pictures unit, according to people familiar with the matter who spoke to The Wall Street Journal. The revamp, which would separate the TV and film operations, could be announced as soon as today. Viacom rose 1% in the premarket.\nKansas City Southern(KSU) – Kansas City Southern said the latest takeover bid from Canadian Pacific Railway(CP) is superior to the one it previously agreed to with Canadian National Railway(CNI). Canadian National now has five days to improve its offer, should it choose to do so. Canadian Pacific rallied 0.9% in premarket trading.\nWalt Disney(DIS) – Disney will show the remainder of its 2021 movie releases exclusively in theaters, rather than making them simultaneously available on its Disney+ streaming service. Disney’s “Shang-Chi and the Legend of the 10 Rings” topped the weekend box office once again following its record Labor Day weekend performance, with that movie showing exclusively in theaters.\nAlibaba(BABA) – Alibaba fell 1.7% in premarket action.\nApple(AAPL) – Epic Games will appeal Friday’s ruling that Apple’s app store was not an illegal monopoly. Epic did win a partial victory in the case, with the judge ruling that Apple must allow developers to include external payment links.\nCarlyle Group(CG) – Carlyle is considering a $6 billion sale or initial public offering for packaging company Novolex, according to a Bloomberg report. The private-equity firm bought Novolex for an undisclosed amount in November 2016.\nMGM Resorts(MGM) – MGM rose 1.5% in the premarket after Bernstein upgraded the resort operator’s stock to “outperform” from “market perform,” citing its strong presence in the gaming and sports betting industry as well as moves to divest the company’s real estate portfolio.\nPfizer(PFE) – Pfizer’s Covid-19 vaccine – developed in conjunction with German partner BioNTech(BNTX) – could be authorized for use in children aged 5-11 as soon as next month, according to two sources familiar with the situation who spoke to Reuters. Pfizer is expected to have enough study data by then to submit an application for emergency use authorization to the Food and Drug Administration. BioNTech added 1.1% in premarket trading.","news_type":1,"symbols_score_info":{".IXIC":0.9,".SPX":0.9,"YMmain":0.9,"PFE":0.9,"CG":0.9,"AAPL":0.9,"BNTX":0.9,"ESmain":0.9,"BABA":0.9,"KSU":0.9,"NQmain":0.9,"VIAC":0.9,"MGM":0.9,".DJI":0.9,"TRU":0.9,"DELL":0.9,"DIS":0.9,"SPCE":0.9}},"isVote":1,"tweetType":1,"viewCount":2698,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":888532304,"gmtCreate":1631505972108,"gmtModify":1631890655212,"author":{"id":"4089370506564720","authorId":"4089370506564720","name":"Applemh1928","avatar":"https://static.tigerbbs.com/3b67986ce8802c4167afe02def3d8349","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089370506564720","idStr":"4089370506564720"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/888532304","repostId":"1161862404","repostType":2,"repost":{"id":"1161862404","kind":"news","pubTimestamp":1631503206,"share":"https://www.laohu8.com/m/news/1161862404?lang=zh_CN&edition=full","pubTime":"2021-09-13 11:20","market":"us","language":"en","title":"Tech Stocks Roundup: Google is the 'Cheapest of FAANG'<blockquote>科技股综述：谷歌是“FAANG中最便宜的”</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1161862404","media":"Thestreet","summary":"Apple (AAPL) investor expectations \"remain muted\" ahead of the computer giant's iPhone 13 unveiling","content":"<p>Apple (AAPL) investor expectations \"remain muted\" ahead of the computer giant's iPhone 13 unveiling, setting up a busy fall with product launches, a Morgan Stanley analyst said.</p><p><blockquote>摩根士丹利分析师表示，在这家计算机巨头iPhone 13发布之前，苹果(AAPL)投资者的预期“仍然低迷”，导致秋季产品发布繁忙。</blockquote></p><p> Analyst Katy Huberty discussed investor expectations leading up to Apple's annual event, dubbed California Streaming, which is set for Tuesday. \"Investor expectations remain muted, which creates a compelling setup into the fall should early iPhone 13 data points outperform expectations,\" the analyst said in a research note.</p><p><blockquote>分析师凯蒂·休伯蒂(Katy Huberty)讨论了投资者对苹果年度活动（名为“加州流媒体”）的预期，该活动定于周二举行。该分析师在一份研究报告中表示：“投资者的预期仍然低迷，如果iPhone 13早期数据点超出预期，这将为秋季创造一个引人注目的环境。”</blockquote></p><p> Huberty said that based on conversations with her Apple supply chain research colleagues, \"we expect the fall of 2021 to be another busy period of product launches, with the iPhone 13 family, the Apple Watch 7, AirPods, 3, new iPads, and new MacBook Pros with M1 all expected to be released before year-end.\"</p><p><blockquote>Huberty表示，根据与苹果供应链研究同事的对话，“我们预计2021年秋季将是另一个产品发布的繁忙时期，iPhone 13系列、苹果Watch 7、AirPods、3、新款iPad以及配备M1的新款MacBook Pro预计都将在年底前发布。”</blockquote></p><p> Investors expect the iPhone 13 to be a more \"evolutionary\" product cycle with fewer significant technology upgrades compared with iPhone 12, she said. The analyst said the iPhone launch event has not been a major stock catalyst. Over the past seven years, Apple shares have risen just 1% on average in the week following the event.</p><p><blockquote>她表示，投资者预计iPhone 13将是一个更具“进化性”的产品周期，与iPhone 12相比，重大技术升级较少。该分析师表示，iPhone发布会并不是主要的股票催化剂。过去七年来，苹果股价在事件发生后一周平均仅上涨1%。</blockquote></p><p> \"Should early iPhone 13 demand data exceed buy-side expectations,\" Huberty said, \"we'd expect Apple shares to rerate higher and likely trade between our $168 base and $245 bull-case valuations, driven by both positive estimate revisions and multiple expansion.\"</p><p><blockquote>Huberty表示：“如果早期iPhone 13需求数据超出买方预期，我们预计苹果股价将重新估值更高，并可能在积极的预估修正和倍数的推动下，在168美元的基础估值和245美元的牛市估值之间交易扩张。”</blockquote></p><p> In terms of positioning ahead of the event, Huberty said \"we still believe the majority of institutional investors are positioned as neutral to negative, despite the fact that Apple shares have rallied over 20% in the past 3 months following a number of App Store headlines that have resolved a handful of existing lawsuits/investigations.\"</p><p><blockquote>在活动前的定位方面，Huberty表示：“我们仍然认为大多数机构投资者的定位是中性至负面，尽管在应用商店发布大量头条新闻后，苹果股价在过去3个月内上涨了20%以上。”已经解决了一些现有的诉讼/调查。”</blockquote></p><p> Piper Sandler analyst Harsh Kumar raised the firm's price target on Apple to $175 from $165 and reiterated an overweight rating on the shares. Baird analysts boosted their price target for Apple to $170 from $160 a share, saying they \"continue to view [the] shares as attractive for long-term-oriented investors.\"</p><p><blockquote>Piper Sandler分析师Harsh Kumar将苹果的目标股价从165美元上调至175美元，并重申了跑赢大盘对该股的评级。Baird分析师将苹果的目标股价从每股160美元上调至170美元，称他们“继续认为该股对长期投资者具有吸引力”。</blockquote></p><p> Apple and Alphabet's Google (GOOGL) - Get Alphabet Inc. Class A Report will be required under a new South Korean law to open their application stores to alternative payment systems. The bill was passed by South Korea’s National Assembly, The Wall Street Journal reported, and it is the first in the world to dent the companies’ dominance over how apps on their platforms sell their digital goods.</p><p><blockquote>根据韩国新法律，苹果和Alphabet的谷歌（GOOGL）-获取Alphabet公司A级报告将被要求向替代支付系统开放其应用商店。据《华尔街日报》报道，该法案由韩国国会通过，这是世界上第一个削弱公司对其平台上的应用程序销售数字商品的主导地位的法案。</blockquote></p><p> The legislation amends South Korea’s Telecommunications Business Act to prevent large app-market operators from requiring the use of their in-app purchasing systems. It also bans operators from unreasonably delaying the approval of apps or deleting them from the marketplace. Companies that fail to comply could be fined up to 3% of their South Korean revenue by the Korea Communications Commission.</p><p><blockquote>该立法修订了韩国的《电信商业法》，以防止大型应用市场运营商要求使用其应用内购买系统。它还禁止运营商不合理地推迟应用程序的批准或从市场上删除它们。不遵守规定的公司可能会被韩国通信委员会处以高达其韩国收入3%的罚款。</blockquote></p><p> The bill in Korea has been nicknamed the “Google power-abuse-prevention law” by some lawmakers and media. Google’s Play Store accounted for 75% of mobile app downloads globally in the second quarter. Apple accounted for 65% of app-store consumer spending on in-app purchases and subscriptions during the same quarter, the Journal reported, citing App Annie, a mobile-app analytics firm.</p><p><blockquote>韩国的这项法案被一些立法者和媒体戏称为“谷歌滥用权力预防法”。谷歌Play商店第二季度占全球移动应用下载量的75%。《华尔街日报》援引移动应用分析公司App Annie的报道称，同一季度，苹果占App Store消费者应用内购买和订阅支出的65%。</blockquote></p><p> Apple and Google are facing lawsuits and investigations in several countries.</p><p><blockquote>苹果和谷歌在多个国家面临诉讼和调查。</blockquote></p><p> Alphabet and Apple are holdings in Jim Cramer's Action Alerts PLUS investing club. Want to be alerted before Jim Cramer buys or sells these stocks? Learn more now.</p><p><blockquote>Alphabet和苹果持有吉姆·克莱默的Action Alerts PLUS投资俱乐部的股份。想在吉姆·克莱默购买或出售这些股票之前收到提醒吗？立即了解更多信息。</blockquote></p><p> Here is a breakdown list of the technology and FAANG stocks to watch right now based on their performance over the past week:</p><p><blockquote>以下是根据过去一周的表现，目前值得关注的科技股和FAANG股票的细分列表：</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tech Stocks Roundup: Google is the 'Cheapest of FAANG'<blockquote>科技股综述：谷歌是“FAANG中最便宜的”</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTech Stocks Roundup: Google is the 'Cheapest of FAANG'<blockquote>科技股综述：谷歌是“FAANG中最便宜的”</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Thestreet</strong><span class=\"h-time small\">2021-09-13 11:20</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Apple (AAPL) investor expectations \"remain muted\" ahead of the computer giant's iPhone 13 unveiling, setting up a busy fall with product launches, a Morgan Stanley analyst said.</p><p><blockquote>摩根士丹利分析师表示，在这家计算机巨头iPhone 13发布之前，苹果(AAPL)投资者的预期“仍然低迷”，导致秋季产品发布繁忙。</blockquote></p><p> Analyst Katy Huberty discussed investor expectations leading up to Apple's annual event, dubbed California Streaming, which is set for Tuesday. \"Investor expectations remain muted, which creates a compelling setup into the fall should early iPhone 13 data points outperform expectations,\" the analyst said in a research note.</p><p><blockquote>分析师凯蒂·休伯蒂(Katy Huberty)讨论了投资者对苹果年度活动（名为“加州流媒体”）的预期，该活动定于周二举行。该分析师在一份研究报告中表示：“投资者的预期仍然低迷，如果iPhone 13早期数据点超出预期，这将为秋季创造一个引人注目的环境。”</blockquote></p><p> Huberty said that based on conversations with her Apple supply chain research colleagues, \"we expect the fall of 2021 to be another busy period of product launches, with the iPhone 13 family, the Apple Watch 7, AirPods, 3, new iPads, and new MacBook Pros with M1 all expected to be released before year-end.\"</p><p><blockquote>Huberty表示，根据与苹果供应链研究同事的对话，“我们预计2021年秋季将是另一个产品发布的繁忙时期，iPhone 13系列、苹果Watch 7、AirPods、3、新款iPad以及配备M1的新款MacBook Pro预计都将在年底前发布。”</blockquote></p><p> Investors expect the iPhone 13 to be a more \"evolutionary\" product cycle with fewer significant technology upgrades compared with iPhone 12, she said. The analyst said the iPhone launch event has not been a major stock catalyst. Over the past seven years, Apple shares have risen just 1% on average in the week following the event.</p><p><blockquote>她表示，投资者预计iPhone 13将是一个更具“进化性”的产品周期，与iPhone 12相比，重大技术升级较少。该分析师表示，iPhone发布会并不是主要的股票催化剂。过去七年来，苹果股价在事件发生后一周平均仅上涨1%。</blockquote></p><p> \"Should early iPhone 13 demand data exceed buy-side expectations,\" Huberty said, \"we'd expect Apple shares to rerate higher and likely trade between our $168 base and $245 bull-case valuations, driven by both positive estimate revisions and multiple expansion.\"</p><p><blockquote>Huberty表示：“如果早期iPhone 13需求数据超出买方预期，我们预计苹果股价将重新估值更高，并可能在积极的预估修正和倍数的推动下，在168美元的基础估值和245美元的牛市估值之间交易扩张。”</blockquote></p><p> In terms of positioning ahead of the event, Huberty said \"we still believe the majority of institutional investors are positioned as neutral to negative, despite the fact that Apple shares have rallied over 20% in the past 3 months following a number of App Store headlines that have resolved a handful of existing lawsuits/investigations.\"</p><p><blockquote>在活动前的定位方面，Huberty表示：“我们仍然认为大多数机构投资者的定位是中性至负面，尽管在应用商店发布大量头条新闻后，苹果股价在过去3个月内上涨了20%以上。”已经解决了一些现有的诉讼/调查。”</blockquote></p><p> Piper Sandler analyst Harsh Kumar raised the firm's price target on Apple to $175 from $165 and reiterated an overweight rating on the shares. Baird analysts boosted their price target for Apple to $170 from $160 a share, saying they \"continue to view [the] shares as attractive for long-term-oriented investors.\"</p><p><blockquote>Piper Sandler分析师Harsh Kumar将苹果的目标股价从165美元上调至175美元，并重申了跑赢大盘对该股的评级。Baird分析师将苹果的目标股价从每股160美元上调至170美元，称他们“继续认为该股对长期投资者具有吸引力”。</blockquote></p><p> Apple and Alphabet's Google (GOOGL) - Get Alphabet Inc. Class A Report will be required under a new South Korean law to open their application stores to alternative payment systems. The bill was passed by South Korea’s National Assembly, The Wall Street Journal reported, and it is the first in the world to dent the companies’ dominance over how apps on their platforms sell their digital goods.</p><p><blockquote>根据韩国新法律，苹果和Alphabet的谷歌（GOOGL）-获取Alphabet公司A级报告将被要求向替代支付系统开放其应用商店。据《华尔街日报》报道，该法案由韩国国会通过，这是世界上第一个削弱公司对其平台上的应用程序销售数字商品的主导地位的法案。</blockquote></p><p> The legislation amends South Korea’s Telecommunications Business Act to prevent large app-market operators from requiring the use of their in-app purchasing systems. It also bans operators from unreasonably delaying the approval of apps or deleting them from the marketplace. Companies that fail to comply could be fined up to 3% of their South Korean revenue by the Korea Communications Commission.</p><p><blockquote>该立法修订了韩国的《电信商业法》，以防止大型应用市场运营商要求使用其应用内购买系统。它还禁止运营商不合理地推迟应用程序的批准或从市场上删除它们。不遵守规定的公司可能会被韩国通信委员会处以高达其韩国收入3%的罚款。</blockquote></p><p> The bill in Korea has been nicknamed the “Google power-abuse-prevention law” by some lawmakers and media. Google’s Play Store accounted for 75% of mobile app downloads globally in the second quarter. Apple accounted for 65% of app-store consumer spending on in-app purchases and subscriptions during the same quarter, the Journal reported, citing App Annie, a mobile-app analytics firm.</p><p><blockquote>韩国的这项法案被一些立法者和媒体戏称为“谷歌滥用权力预防法”。谷歌Play商店第二季度占全球移动应用下载量的75%。《华尔街日报》援引移动应用分析公司App Annie的报道称，同一季度，苹果占App Store消费者应用内购买和订阅支出的65%。</blockquote></p><p> Apple and Google are facing lawsuits and investigations in several countries.</p><p><blockquote>苹果和谷歌在多个国家面临诉讼和调查。</blockquote></p><p> Alphabet and Apple are holdings in Jim Cramer's Action Alerts PLUS investing club. Want to be alerted before Jim Cramer buys or sells these stocks? Learn more now.</p><p><blockquote>Alphabet和苹果持有吉姆·克莱默的Action Alerts PLUS投资俱乐部的股份。想在吉姆·克莱默购买或出售这些股票之前收到提醒吗？立即了解更多信息。</blockquote></p><p> Here is a breakdown list of the technology and FAANG stocks to watch right now based on their performance over the past week:</p><p><blockquote>以下是根据过去一周的表现，目前值得关注的科技股和FAANG股票的细分列表：</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/technology/tech-stocks-roundup-google-is-the-cheapest-of-faang?puc=yahoo&cm_ven=YAHOO\">Thestreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOG":"谷歌","AAPL":"苹果"},"source_url":"https://www.thestreet.com/technology/tech-stocks-roundup-google-is-the-cheapest-of-faang?puc=yahoo&cm_ven=YAHOO","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161862404","content_text":"Apple (AAPL) investor expectations \"remain muted\" ahead of the computer giant's iPhone 13 unveiling, setting up a busy fall with product launches, a Morgan Stanley analyst said.\nAnalyst Katy Huberty discussed investor expectations leading up to Apple's annual event, dubbed California Streaming, which is set for Tuesday. \"Investor expectations remain muted, which creates a compelling setup into the fall should early iPhone 13 data points outperform expectations,\" the analyst said in a research note.\nHuberty said that based on conversations with her Apple supply chain research colleagues, \"we expect the fall of 2021 to be another busy period of product launches, with the iPhone 13 family, the Apple Watch 7, AirPods, 3, new iPads, and new MacBook Pros with M1 all expected to be released before year-end.\"\nInvestors expect the iPhone 13 to be a more \"evolutionary\" product cycle with fewer significant technology upgrades compared with iPhone 12, she said. The analyst said the iPhone launch event has not been a major stock catalyst. Over the past seven years, Apple shares have risen just 1% on average in the week following the event.\n\"Should early iPhone 13 demand data exceed buy-side expectations,\" Huberty said, \"we'd expect Apple shares to rerate higher and likely trade between our $168 base and $245 bull-case valuations, driven by both positive estimate revisions and multiple expansion.\"\nIn terms of positioning ahead of the event, Huberty said \"we still believe the majority of institutional investors are positioned as neutral to negative, despite the fact that Apple shares have rallied over 20% in the past 3 months following a number of App Store headlines that have resolved a handful of existing lawsuits/investigations.\"\nPiper Sandler analyst Harsh Kumar raised the firm's price target on Apple to $175 from $165 and reiterated an overweight rating on the shares. Baird analysts boosted their price target for Apple to $170 from $160 a share, saying they \"continue to view [the] shares as attractive for long-term-oriented investors.\"\nApple and Alphabet's Google (GOOGL) - Get Alphabet Inc. Class A Report will be required under a new South Korean law to open their application stores to alternative payment systems. The bill was passed by South Korea’s National Assembly, The Wall Street Journal reported, and it is the first in the world to dent the companies’ dominance over how apps on their platforms sell their digital goods.\nThe legislation amends South Korea’s Telecommunications Business Act to prevent large app-market operators from requiring the use of their in-app purchasing systems. It also bans operators from unreasonably delaying the approval of apps or deleting them from the marketplace. Companies that fail to comply could be fined up to 3% of their South Korean revenue by the Korea Communications Commission.\nThe bill in Korea has been nicknamed the “Google power-abuse-prevention law” by some lawmakers and media. Google’s Play Store accounted for 75% of mobile app downloads globally in the second quarter. Apple accounted for 65% of app-store consumer spending on in-app purchases and subscriptions during the same quarter, the Journal reported, citing App Annie, a mobile-app analytics firm.\nApple and Google are facing lawsuits and investigations in several countries.\nAlphabet and Apple are holdings in Jim Cramer's Action Alerts PLUS investing club. Want to be alerted before Jim Cramer buys or sells these stocks? Learn more now.\nHere is a breakdown list of the technology and FAANG stocks to watch right now based on their performance over the past week:","news_type":1,"symbols_score_info":{"AAPL":0.9,"GOOG":0.9}},"isVote":1,"tweetType":1,"viewCount":2974,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888080897,"gmtCreate":1631413222419,"gmtModify":1631890655217,"author":{"id":"4089370506564720","authorId":"4089370506564720","name":"Applemh1928","avatar":"https://static.tigerbbs.com/3b67986ce8802c4167afe02def3d8349","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089370506564720","idStr":"4089370506564720"},"themes":[],"htmlText":"Like and comment thanks","listText":"Like and comment thanks","text":"Like and comment thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/888080897","repostId":"1189654544","repostType":4,"repost":{"id":"1189654544","kind":"news","pubTimestamp":1631406130,"share":"https://www.laohu8.com/m/news/1189654544?lang=zh_CN&edition=full","pubTime":"2021-09-12 08:22","market":"us","language":"en","title":"US IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week<blockquote>美国IPO周：秋季IPO市场以10周IPO拉开帷幕</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1189654544","media":"Renaissance Capital","summary":"After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion i","content":"<p>After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week ahead.</p><p><blockquote>在短暂的假期周经历了一波发行之后，未来一周将有10起IPO计划筹集超过30亿美元的资金。</blockquote></p><p> Tech consultancy <b>Thoughtworks</b>(TWKS) plans to raise $700 million at a $6.3 billion market cap. This agile software developer provides premium, end-to-end digital strategy, design, and engineering services to more than 300 enterprise customers. The company grew revenue at a 14% CAGR from 2017 to 2020, and expanded margins in 2020 and the 1H21.</p><p><blockquote>技术咨询<b>Thoughtworks</b>(TWKS)计划以63亿美元的市值筹集7亿美元。这家敏捷软件开发商为300多家企业客户提供优质的端到端数字战略、设计和工程服务。从2017年到2020年，该公司的收入复合年增长率为14%，并在2020年和2021年上半年扩大了利润率。</blockquote></p><p> Swiss running shoe brand <b>On Holding</b>(ONON) plans to raise $591 million at a $5.9 billion market cap. On is a global provider of premium athletic footwear, apparel, and accessories that are designed using sustainable materials and its proprietary technology. The company has demonstrated growth and profitability, though it faces significant competition from other well-known sportswear brands.</p><p><blockquote>瑞士跑鞋品牌<b>持有时</b>(ONON)计划以59亿美元的市值筹集5.91亿美元。On是一家全球优质运动鞋、服装和配饰供应商，采用可持续材料及其专有技术设计。尽管面临来自其他知名运动服装品牌的激烈竞争，但该公司已展现出增长和盈利能力。</blockquote></p><p> After ending talks to go public via SPAC,<b>Sportradar Group</b>(SRAD) plans to raise $504 million at a $7.9 billion market cap. Covering over 750,000 events annually across 83 sports, this Swiss company provides software, data, and content to sports leagues, betting operators, and media companies. Sportradar is profitable, and growth accelerated in the 1H21 as live sports resumed.</p><p><blockquote>在结束通过SPAC上市的谈判后，<b>Sportradar集团</b>(SRAD)计划以79亿美元的市值筹集5.04亿美元。这家瑞士公司每年报道83项运动的750,000多场赛事，为体育联盟、博彩运营商和媒体公司提供软件、数据和内容。Sportradar已实现盈利，随着体育直播的恢复，2021年上半年增长加速。</blockquote></p><p> Drive-thru coffee chain <b>Dutch Bros</b>(BROS) plans to raise $400 million at a $3.3 billion market cap. This Oregon-based company has a chain of 471 drive-thru coffee shops in the Western US, and it has been able to maintain a track record of same-store sales growth as it has expanded to new states. Insiders received pre-IPO dividends and will sell shares back to the company.</p><p><blockquote>得来速咖啡连锁店<b>荷兰兄弟</b>(BROS)计划以33亿美元的市值筹集4亿美元。这家总部位于俄勒冈州的公司在美国西部拥有471家得来速咖啡店连锁店，随着业务扩展到新州，它一直能够保持同店销售增长的记录。内部人士收到了IPO前的股息，并将把股票卖回给公司。</blockquote></p><p> Healthcare intelligence platform <b>Definitive Healthcare</b>(DH) plans to raise $350 million at a $3.3 billion market cap. This company provides a healthcare commercial intelligence and analytics platform, helping its customers to analyze, navigate, and sell into the complex healthcare ecosystem. Unprofitable with strong growth, Definitive Healthcare will be leveraged post-IPO.</p><p><blockquote>医疗智能平台<b>权威医疗保健</b>(DH)计划以33亿美元的市值筹集3.5亿美元。该公司提供医疗保健商业智能和分析平台，帮助其客户分析、导航和销售复杂的医疗保健生态系统。由于增长强劲，Definitive Healthcare尚未盈利，但将在IPO后进行杠杆化。</blockquote></p><p> Identity management platform <b>ForgeRock</b>(FORG) plans to raise $248 million at a $2.1 billion market cap. The company provides identity and access management software, with a platform to provision, authenticate, and govern all types of digital identities. Unprofitable with high sales and marketing expenses, ForgeRock is a leading next-gen provider in the multi-billion-dollar identity and access market.</p><p><blockquote>身份管理平台<b>ForgeRock</b>(FORG)计划以21亿美元的市值筹集2.48亿美元。该公司提供身份和访问管理软件，以及一个提供、认证和管理所有类型数字身份的平台。由于销售和营销费用高昂，ForgeRock无利可图，是价值数十亿美元的身份和访问市场中领先的下一代提供商。</blockquote></p><p> Immunology biotech <b>DICE Therapeutics</b>(DICE) plans to raise $160 million at a $550 million market cap. This biotech is developing oral small molecule therapies to treat chronic diseases in immunology and other therapeutic areas. DICE plans to initiate a Phase 1 trial of its lead candidate S011806, an oral antagonist with a variety of immunology indications.</p><p><blockquote>免疫学生物技术<b>骰子疗法</b>(DICE)计划以5.5亿美元的市值筹集1.6亿美元。这家生物技术公司正在开发口服小分子疗法，以治疗免疫学和其他治疗领域的慢性疾病。DICE计划启动其主要候选药物S011806的1期试验，这是一种具有多种免疫学适应症的口服拮抗剂。</blockquote></p><p> Surgical robotics developer <b>PROCEPT BioRobotics</b>(PRCT) plans to raise $127 million at a $1.1 billion market cap. This commercial-stage company develops surgical robotic systems for minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics is highly unprofitable and saw revenue increase more than sixfold in the 1H21.</p><p><blockquote>手术机器人开发商<b>PROCEPT生物机器人</b>(PRCT)计划以11亿美元的市值筹集1.27亿美元。这家商业阶段的公司开发用于微创泌尿外科手术的手术机器人系统，最初的重点是治疗良性前列腺增生。PROCEPT BioRobotics非常无利可图，2021年上半年收入增长了六倍多。</blockquote></p><p> Oncology biotech <b>Tyra Biosciences</b>(TYRA) plans to raise $101 million at a $584 million market cap. This preclinical biotech is developing FGFR kinase inhibitors for cancer, specifically solid tumors. Tyra’s lead candidate is initially focused on bladder cancer, and the company expects to submit an IND for it in mid-2022.</p><p><blockquote>肿瘤生物技术<b>泰拉生物科学公司</b>(TYRA)计划以5.84亿美元的市值筹集1.01亿美元。这家临床前生物技术公司正在开发用于癌症，特别是实体瘤的FGFR激酶抑制剂。Tyra的主要候选药物最初专注于膀胱癌，该公司预计将于2022年中期提交IND。</blockquote></p><p> Micro-cap gas delivery service <b>EzFill Holdings</b>(EZFL) plans to raise $25 million at a $104 million market cap. This mobile-fueling company provides an on-demand fuel delivery service in Florida via mobile app. Highly unprofitable with explosive growth, EzFill states that it is the dominant player in the South Florida market.</p><p><blockquote>微帽气体输送服务<b>埃兹菲尔控股</b>(EZFL)计划以1.04亿美元的市值筹集2500万美元。这家移动加油公司通过移动应用程序在佛罗里达州提供按需加油服务。由于爆炸性增长，EzFill表示，它是南佛罗里达州市场的主导者。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/718698ff98644c4026f32efe91d076c6\" tg-width=\"1128\" tg-height=\"684\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/97fe13300d9e4cf61effc59b9706776a\" tg-width=\"1129\" tg-height=\"247\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>IPO Market Snapshot</b></p><p><blockquote><b>IPO市场快照</b></blockquote></p><p> The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 9/9/21, the Renaissance IPO Index was up 7.7% year-to-date, while the S&P 500 was up 19.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 11.0% year-to-date, while the ACWX was up 10.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.</p><p><blockquote>文艺复兴IPO指数是新上市公司的市值加权篮子。截至9/9/21，文艺复兴IPO指数今年迄今上涨了7.7%，而标普500上涨了19.6%。Renaissance Capital的IPO ETF（纽约证券交易所股票代码：IPO）跟踪该指数，持有的顶级ETF包括Snowflake（SNOW）和Palantir Technologies（PLTR）。Renaissance International IPO指数今年迄今下跌11.0%，而ACWX指数上涨10.0%。Renaissance Capital的国际IPO ETF（纽约证券交易所股票代码：IPOS）跟踪该指数，持有的顶级ETF包括思摩尔国际和殷拓合伙人。</blockquote></p><p></p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week<blockquote>美国IPO周：秋季IPO市场以10周IPO拉开帷幕</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week<blockquote>美国IPO周：秋季IPO市场以10周IPO拉开帷幕</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Renaissance Capital</strong><span class=\"h-time small\">2021-09-12 08:22</span>\n</p>\n</h4>\n</header>\n<article>\n<p>After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week ahead.</p><p><blockquote>在短暂的假期周经历了一波发行之后，未来一周将有10起IPO计划筹集超过30亿美元的资金。</blockquote></p><p> Tech consultancy <b>Thoughtworks</b>(TWKS) plans to raise $700 million at a $6.3 billion market cap. This agile software developer provides premium, end-to-end digital strategy, design, and engineering services to more than 300 enterprise customers. The company grew revenue at a 14% CAGR from 2017 to 2020, and expanded margins in 2020 and the 1H21.</p><p><blockquote>技术咨询<b>Thoughtworks</b>(TWKS)计划以63亿美元的市值筹集7亿美元。这家敏捷软件开发商为300多家企业客户提供优质的端到端数字战略、设计和工程服务。从2017年到2020年，该公司的收入复合年增长率为14%，并在2020年和2021年上半年扩大了利润率。</blockquote></p><p> Swiss running shoe brand <b>On Holding</b>(ONON) plans to raise $591 million at a $5.9 billion market cap. On is a global provider of premium athletic footwear, apparel, and accessories that are designed using sustainable materials and its proprietary technology. The company has demonstrated growth and profitability, though it faces significant competition from other well-known sportswear brands.</p><p><blockquote>瑞士跑鞋品牌<b>持有时</b>(ONON)计划以59亿美元的市值筹集5.91亿美元。On是一家全球优质运动鞋、服装和配饰供应商，采用可持续材料及其专有技术设计。尽管面临来自其他知名运动服装品牌的激烈竞争，但该公司已展现出增长和盈利能力。</blockquote></p><p> After ending talks to go public via SPAC,<b>Sportradar Group</b>(SRAD) plans to raise $504 million at a $7.9 billion market cap. Covering over 750,000 events annually across 83 sports, this Swiss company provides software, data, and content to sports leagues, betting operators, and media companies. Sportradar is profitable, and growth accelerated in the 1H21 as live sports resumed.</p><p><blockquote>在结束通过SPAC上市的谈判后，<b>Sportradar集团</b>(SRAD)计划以79亿美元的市值筹集5.04亿美元。这家瑞士公司每年报道83项运动的750,000多场赛事，为体育联盟、博彩运营商和媒体公司提供软件、数据和内容。Sportradar已实现盈利，随着体育直播的恢复，2021年上半年增长加速。</blockquote></p><p> Drive-thru coffee chain <b>Dutch Bros</b>(BROS) plans to raise $400 million at a $3.3 billion market cap. This Oregon-based company has a chain of 471 drive-thru coffee shops in the Western US, and it has been able to maintain a track record of same-store sales growth as it has expanded to new states. Insiders received pre-IPO dividends and will sell shares back to the company.</p><p><blockquote>得来速咖啡连锁店<b>荷兰兄弟</b>(BROS)计划以33亿美元的市值筹集4亿美元。这家总部位于俄勒冈州的公司在美国西部拥有471家得来速咖啡店连锁店，随着业务扩展到新州，它一直能够保持同店销售增长的记录。内部人士收到了IPO前的股息，并将把股票卖回给公司。</blockquote></p><p> Healthcare intelligence platform <b>Definitive Healthcare</b>(DH) plans to raise $350 million at a $3.3 billion market cap. This company provides a healthcare commercial intelligence and analytics platform, helping its customers to analyze, navigate, and sell into the complex healthcare ecosystem. Unprofitable with strong growth, Definitive Healthcare will be leveraged post-IPO.</p><p><blockquote>医疗智能平台<b>权威医疗保健</b>(DH)计划以33亿美元的市值筹集3.5亿美元。该公司提供医疗保健商业智能和分析平台，帮助其客户分析、导航和销售复杂的医疗保健生态系统。由于增长强劲，Definitive Healthcare尚未盈利，但将在IPO后进行杠杆化。</blockquote></p><p> Identity management platform <b>ForgeRock</b>(FORG) plans to raise $248 million at a $2.1 billion market cap. The company provides identity and access management software, with a platform to provision, authenticate, and govern all types of digital identities. Unprofitable with high sales and marketing expenses, ForgeRock is a leading next-gen provider in the multi-billion-dollar identity and access market.</p><p><blockquote>身份管理平台<b>ForgeRock</b>(FORG)计划以21亿美元的市值筹集2.48亿美元。该公司提供身份和访问管理软件，以及一个提供、认证和管理所有类型数字身份的平台。由于销售和营销费用高昂，ForgeRock无利可图，是价值数十亿美元的身份和访问市场中领先的下一代提供商。</blockquote></p><p> Immunology biotech <b>DICE Therapeutics</b>(DICE) plans to raise $160 million at a $550 million market cap. This biotech is developing oral small molecule therapies to treat chronic diseases in immunology and other therapeutic areas. DICE plans to initiate a Phase 1 trial of its lead candidate S011806, an oral antagonist with a variety of immunology indications.</p><p><blockquote>免疫学生物技术<b>骰子疗法</b>(DICE)计划以5.5亿美元的市值筹集1.6亿美元。这家生物技术公司正在开发口服小分子疗法，以治疗免疫学和其他治疗领域的慢性疾病。DICE计划启动其主要候选药物S011806的1期试验，这是一种具有多种免疫学适应症的口服拮抗剂。</blockquote></p><p> Surgical robotics developer <b>PROCEPT BioRobotics</b>(PRCT) plans to raise $127 million at a $1.1 billion market cap. This commercial-stage company develops surgical robotic systems for minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics is highly unprofitable and saw revenue increase more than sixfold in the 1H21.</p><p><blockquote>手术机器人开发商<b>PROCEPT生物机器人</b>(PRCT)计划以11亿美元的市值筹集1.27亿美元。这家商业阶段的公司开发用于微创泌尿外科手术的手术机器人系统，最初的重点是治疗良性前列腺增生。PROCEPT BioRobotics非常无利可图，2021年上半年收入增长了六倍多。</blockquote></p><p> Oncology biotech <b>Tyra Biosciences</b>(TYRA) plans to raise $101 million at a $584 million market cap. This preclinical biotech is developing FGFR kinase inhibitors for cancer, specifically solid tumors. Tyra’s lead candidate is initially focused on bladder cancer, and the company expects to submit an IND for it in mid-2022.</p><p><blockquote>肿瘤生物技术<b>泰拉生物科学公司</b>(TYRA)计划以5.84亿美元的市值筹集1.01亿美元。这家临床前生物技术公司正在开发用于癌症，特别是实体瘤的FGFR激酶抑制剂。Tyra的主要候选药物最初专注于膀胱癌，该公司预计将于2022年中期提交IND。</blockquote></p><p> Micro-cap gas delivery service <b>EzFill Holdings</b>(EZFL) plans to raise $25 million at a $104 million market cap. This mobile-fueling company provides an on-demand fuel delivery service in Florida via mobile app. Highly unprofitable with explosive growth, EzFill states that it is the dominant player in the South Florida market.</p><p><blockquote>微帽气体输送服务<b>埃兹菲尔控股</b>(EZFL)计划以1.04亿美元的市值筹集2500万美元。这家移动加油公司通过移动应用程序在佛罗里达州提供按需加油服务。由于爆炸性增长，EzFill表示，它是南佛罗里达州市场的主导者。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/718698ff98644c4026f32efe91d076c6\" tg-width=\"1128\" tg-height=\"684\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/97fe13300d9e4cf61effc59b9706776a\" tg-width=\"1129\" tg-height=\"247\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>IPO Market Snapshot</b></p><p><blockquote><b>IPO市场快照</b></blockquote></p><p> The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 9/9/21, the Renaissance IPO Index was up 7.7% year-to-date, while the S&P 500 was up 19.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 11.0% year-to-date, while the ACWX was up 10.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.</p><p><blockquote>文艺复兴IPO指数是新上市公司的市值加权篮子。截至9/9/21，文艺复兴IPO指数今年迄今上涨了7.7%，而标普500上涨了19.6%。Renaissance Capital的IPO ETF（纽约证券交易所股票代码：IPO）跟踪该指数，持有的顶级ETF包括Snowflake（SNOW）和Palantir Technologies（PLTR）。Renaissance International IPO指数今年迄今下跌11.0%，而ACWX指数上涨10.0%。Renaissance Capital的国际IPO ETF（纽约证券交易所股票代码：IPOS）跟踪该指数，持有的顶级ETF包括思摩尔国际和殷拓合伙人。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.renaissancecapital.com/IPO-Center/News/85972/US-IPO-Week-Ahead-The-Fall-IPO-market-kicks-off-with-a-10-IPO-week\">Renaissance Capital</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DH":"Definitive Healthcare Corp.",".DJI":"道琼斯","BROS":"Dutch Bros Inc.","FORG":"ForgeRock, Inc.","TYRA":"Tyra Biosciences, Inc.","ONON":"On Holding AG","TWKS":"Thoughtworks Holding Inc.",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","SRAD":"Sportradar Group AG","PRCT":"PROCEPT BioRobotics","DICE":"DICE Therapeutics, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/85972/US-IPO-Week-Ahead-The-Fall-IPO-market-kicks-off-with-a-10-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189654544","content_text":"After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week ahead.\nTech consultancy Thoughtworks(TWKS) plans to raise $700 million at a $6.3 billion market cap. This agile software developer provides premium, end-to-end digital strategy, design, and engineering services to more than 300 enterprise customers. The company grew revenue at a 14% CAGR from 2017 to 2020, and expanded margins in 2020 and the 1H21.\nSwiss running shoe brand On Holding(ONON) plans to raise $591 million at a $5.9 billion market cap. On is a global provider of premium athletic footwear, apparel, and accessories that are designed using sustainable materials and its proprietary technology. The company has demonstrated growth and profitability, though it faces significant competition from other well-known sportswear brands.\nAfter ending talks to go public via SPAC,Sportradar Group(SRAD) plans to raise $504 million at a $7.9 billion market cap. Covering over 750,000 events annually across 83 sports, this Swiss company provides software, data, and content to sports leagues, betting operators, and media companies. Sportradar is profitable, and growth accelerated in the 1H21 as live sports resumed.\nDrive-thru coffee chain Dutch Bros(BROS) plans to raise $400 million at a $3.3 billion market cap. This Oregon-based company has a chain of 471 drive-thru coffee shops in the Western US, and it has been able to maintain a track record of same-store sales growth as it has expanded to new states. Insiders received pre-IPO dividends and will sell shares back to the company.\nHealthcare intelligence platform Definitive Healthcare(DH) plans to raise $350 million at a $3.3 billion market cap. This company provides a healthcare commercial intelligence and analytics platform, helping its customers to analyze, navigate, and sell into the complex healthcare ecosystem. Unprofitable with strong growth, Definitive Healthcare will be leveraged post-IPO.\nIdentity management platform ForgeRock(FORG) plans to raise $248 million at a $2.1 billion market cap. The company provides identity and access management software, with a platform to provision, authenticate, and govern all types of digital identities. Unprofitable with high sales and marketing expenses, ForgeRock is a leading next-gen provider in the multi-billion-dollar identity and access market.\nImmunology biotech DICE Therapeutics(DICE) plans to raise $160 million at a $550 million market cap. This biotech is developing oral small molecule therapies to treat chronic diseases in immunology and other therapeutic areas. DICE plans to initiate a Phase 1 trial of its lead candidate S011806, an oral antagonist with a variety of immunology indications.\nSurgical robotics developer PROCEPT BioRobotics(PRCT) plans to raise $127 million at a $1.1 billion market cap. This commercial-stage company develops surgical robotic systems for minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics is highly unprofitable and saw revenue increase more than sixfold in the 1H21.\nOncology biotech Tyra Biosciences(TYRA) plans to raise $101 million at a $584 million market cap. This preclinical biotech is developing FGFR kinase inhibitors for cancer, specifically solid tumors. Tyra’s lead candidate is initially focused on bladder cancer, and the company expects to submit an IND for it in mid-2022.\nMicro-cap gas delivery service EzFill Holdings(EZFL) plans to raise $25 million at a $104 million market cap. This mobile-fueling company provides an on-demand fuel delivery service in Florida via mobile app. Highly unprofitable with explosive growth, EzFill states that it is the dominant player in the South Florida market.\n\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 9/9/21, the Renaissance IPO Index was up 7.7% year-to-date, while the S&P 500 was up 19.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 11.0% year-to-date, while the ACWX was up 10.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.","news_type":1,"symbols_score_info":{"FORG":0.9,"DH":0.9,".SPX":0.9,"BROS":0.9,"DICE":0.9,"TWKS":0.9,"TYRA":0.9,"EZFL":0.9,".IXIC":0.9,"SRAD":0.9,".DJI":0.9,"ONON":0.9,"PRCT":0.9}},"isVote":1,"tweetType":1,"viewCount":1831,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}